Date & Time

Wed, 09/03/2008


The 2008 Olympics and competitive athletics in general increasingly confront us with questions about new means of enhancing human performance. As pharmacology, physiology, and technology continue to advance, we will be more and more challenged to re-define what it means to be human.

• If we can substitute drugs or genetic changes for years of training, should we?

• And, if we shouldn’t, why not?


Don Catlin
UCLA, Olympic Laboratory

For more than a quarter century, Dr. Don Catlin has been at the forefront of the global battle against the use of performance-enhancing drugs in sports, and he is often referred to as one of the fathers of drug testing in sport. Dr. Catlin’s research has been vital in the creation of many of the tests currently used to detect performance-enhancing drugs. Among other breakthroughs, he and his team developed the testing methodology that differentiates natural from artificial testosterone; inaugurated the test for darbepoetin, a long-acting form of the blood booster medicine EPO; were first to report the use of a designer steroid (norbolethone) in sport; and marshaled the analytic work behind the BALCO scandal, which involved identifying the designer steroid THG. Dr. Catlin also serves as Professor Emeritus of Molecular and Medical Pharmacology at the UCLA David Geffen School of Medicine and is the author of over 100 articles in scientific publications.


Theodore Friedmann
World Anti-Doping Agency

Dr. Theodore Friedmann is Professor of Pediatrics, Director of the Gene Therapy Program, and Muriel Whitehill Professor of Biomedical Ethics at the University of California San Diego. His scientific and medical interests concern the development of gene therapy for human disease and in that capacity he has served as President of the American Society of Gene Therapy and Newton Abraham Professor at the University of Oxford.


Mark Zeigler
Union-Tribune, Sports Section

Mark Zeigler is an award-winning sports writer with The San Diego Union-Tribune who has covered doping in sports for two decades. He recently returned from Beijing, where he reported on his 11th Olympics (six Summer, five Winter). He has covered sporting events on six continents, including five soccer World Cups, Super Bowls, World Series, NBA Finals, Grand Slam tennis tournaments, World Championships of track and field, and college football bowl games. He has written extensively on the BALCO doping scandal and speaks regularly with BALCO founder Victor Conte about the state of doping in sports. Mark attended Stanford University and received a degree in classical studies.